Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GT Biopharma, Inc. - Common Stock (NQ:GTBP)

2.240 +0.010 (+0.45%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 532,463
Open 2.600
Bid (Size) 2.200 (7)
Ask (Size) 2.300 (20)
Prev. Close 2.230
Today's Range 2.150 - 2.890
52wk Range 1.720 - 10.66
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
EXCLUSIVE: GT Biopharma Advances Relapsed Blood Cancer Therapy Trial To Cohort 2 After Promising Early Safety Results
GTBP announces completion of dosing in Cohort 1 and start of dosing in Cohort 2 of Phase 1 trial for GTB-3650, showing potential for NK cell expansion and increased immunologic activity. Detailed... 
Via Benzinga
GT Biopharma Retail Chatter Soars Most Among Biotechs After Financing Strategy Tweak
The company said it had withdrawn its earlier Form S-1 registration, initially filed with the SEC in December, which sought approval for an automatic mixed securities shelf offering. 
Via Stocktwits
Topics Regulatory Compliance
Exposures Legal Regulatory

Performance

YTD
-23.8%
-23.8%
1 Month
+3.2%
+3.2%
3 Month
+6.7%
+6.7%
6 Month
-24.1%
-24.1%
1 Year
-71.3%
-71.3%

More News

Read More
Traders are paying attention to the gapping stocks in Tuesday's session.
Via Chartmill
What's going on in today's pre-market session
Via Chartmill
GTBP Stock Earnings: GT Biopharma Reported Results for Q2 2024
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
What's Going On With GT Biopharma Stock Tuesday?
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
What's Going On With GT Biopharma Stock?
Via Benzinga
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
US Stocks Mixed; Li Auto Shares Plummet After Q1 Results
Via Benzinga
Why Is Jaguar Health (JAGX) Stock Down 40% Today?
Via InvestorPlace
Why Is Virios Therapeutics (VIRI) Stock Down 44% Today?
Via InvestorPlace
Why Is GT Biopharma (GTBP) Stock Up 143% Today?
Via InvestorPlace
Why Wix.com Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
GTBP Stock Earnings: GT Biopharma Beats EPS for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
GTBP Stock Earnings: GT Biopharma Beats EPS for Q4 2023
Via InvestorPlace

Frequently Asked Questions

Is GT Biopharma, Inc. - Common Stock publicly traded?
Yes, GT Biopharma, Inc. - Common Stock is publicly traded.
What exchange does GT Biopharma, Inc. - Common Stock trade on?
GT Biopharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GT Biopharma, Inc. - Common Stock?
The ticker symbol for GT Biopharma, Inc. - Common Stock is GTBP on the Nasdaq Stock Market
What is the current price of GT Biopharma, Inc. - Common Stock?
The current price of GT Biopharma, Inc. - Common Stock is 2.240
When was GT Biopharma, Inc. - Common Stock last traded?
The last trade of GT Biopharma, Inc. - Common Stock was at 05/19/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.